Ascendis Pharma A/S

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

TransCon hGH · Endocrinology
TransCon hGH is a long-acting human growth hormone (hGH) analog that uses a proprietary technology called TransCon to extend its half-life.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Ascendis Pharma A/S portfolio CI brief
Ascendis Pharma A/S pipeline updates RSS

Frequently asked questions about Ascendis Pharma A/S

What is Ascendis Pharma A/S's pipeline?

Ascendis Pharma A/S has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include TransCon hGH.

Sector hub: All tracked pharma companies